Early augmentation of interleukin (IL)-12 level in the airway of mice administered orally with clarithromycin or intranasally with IL-12 results in alleviation of influenza infection

Journal of Pharmacology and Experimental Therapeutics

Volumn 298, Issue 1, 2001, Pages 362-368

  Tsurita, Minako ^a   Kurokawa, Masahiko ^a   Imakita, Masami ^b,c   Fukuda, Yoshiko ^a   Watanabe, Yukio ^a   Shiraki, Kimiyasu ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c Department of Cardiology   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; FEMALE; IMMUNOMODULATION; INFLUENZA; LUNG LAVAGE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYSTEM; TREATMENT OUTCOME; VIRUS LOAD; VIRUS PNEUMONIA;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; BODY WEIGHT; CLARITHROMYCIN; DOGS; FEMALE; INTERLEUKIN-12; MICE; MICE, INBRED DBA; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; RECOMBINANT PROTEINS; SURVIVAL RATE;

EID: 0034977379     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Toxicity studies on TE-031 (A-56268) I. Acute toxicity test in mice and rats
2. Pathogenesis of influenza virus-induced pneumonia: Involvement of both nitric oxide and oxygen radicals
3. Intranasal interleukin-12 is a powerful adjuvant for protective mucosal immunity
4. Novel features of the respiratory tract T-cell response to influenza virus infection: Lung T cells increase expression of gamma interferon mRNA in vivo and maintain high levels of mRNA expression for interleukin-5 (IL-5) and IL-10
5. Transgenic mice lacking class I major histocompatibility complex-restricted T-cells have delayed viral clearance and increased mortality after influenza virus challenge
6. Cytokines and the acute phase response to influenza virus in mice
7. + T cells
8. Nasal cytokine and chemokine responses in experimental influenza A virus infection: Results of a placebo-controlled trial of intravenous zanamivir treatment
9. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase
10. A kinetic study of immune mediators in the lungs of mice infected with influenza A virus
11. + T cells through IL-12 produced by Listeria-induced macrophages
12. Erythromycin therapy for otitis media with effusion in sinobronchial syndrome
13. Erythromycin promotes monocyte to macrophage differentiation
14. Effect of clarithromycin and azithromycin on production of cytokines by human monocytes
15. Role of natural killer cells in the generation of influenza virus-specific cytotoxic T
16. Interleukin 12 administration enhances Th1 activity but delays recovery from infuenza A virus infection in mice
17. Cascade of fever production in mice infected with influenza virus
18. Kakkon-to suppressed interleukin-1 production responsive to interferon and alleviated influenza infection in mice
19. Antipyretic activity of cinnamyl and related compounds in Kakkon-to, a traditional medicine, in influenza virus-infected mice
20. Inhibitory effect of protein kinase C inhibitor on the replication of influenza type A virus
21. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
22. Interleukin-12 induces stable priming for interferon-γ (IFN-γ) production during differentiation of human T helper (Th) cells and transient IFN-γ production in established Th2 cell clones
23. Role of interleukin-12 primary influenza virus infection
24. Efficacy of Kakkon-to, a traditional herb medicine, in herpes simplex virus type 1 infection in mice
25. Leukotriene B4 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis
26. Erythromycin inhibits neutrophil chemotaxis in bronchoalveoli of diffuse panbronchiolitis
27. Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD
28. Lymphocyte responses and cytokines
29. Role of macrophage cytokines in influenza A virus infections
30. The pathogenesis of infections of the mouse caused by virulent and avirulent variants of an influenza virus
31. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): Cytolytic activity and proliferation of NK cells are differentially regulated by NKSF
32. Therapeutic effect of erythromycin on influenza virus-induced lung injury in mice
33. Inhibitory effect of macrolides on interleukin-8 secretion from cultured human nasal epithelial cells
34. Pathogenicity of influenza virus
35. Role of staphylococcus aureus in the development of influenza pneumonia